A new perspective on brain derived neurotrophin factor polymorphism in L-dopa induced dyskinesia.
Moreau
Caroline
C
Destée
Alain
A
D000978:Antiparkinson Agents / Q000009:adverse effects*; D019208:Brain-Derived Neurotrophic Factor / Q000134:cerebrospinal fluid / Q000235:genetics*; D003342:Corpus Striatum / Q000473:pathology; D004409:Dyskinesia, Drug-Induced / Q000209:etiology* / Q000235:genetics*; D005819:Genetic Markers; D005838:Genotype; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D009473:Neuronal Plasticity / Q000502:physiology; D010300:Parkinson Disease / Q000188:drug therapy / Q000473:pathology; D011110:Polymorphism, Genetic / Q000235:genetics*
D000978:Antiparkinson Agents; D019208:Brain-Derived Neurotrophic Factor; D005819:Genetic Markers; D007980:Levodopa